1-5 of 5
Zdenek Kral
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Viera Sandecka, MD PhD, Ludek Pour, MD, Zdenek Adam, Prof, MD CSc, Martin Stork, MD, Marta Krejci, Prof, MD PhD, Jana Michalcova, MD, Zdenek Kral, MD CSc, Sabina Sevcikova, PhD, Zdeněk Řehák, MD PhD, Renata Koukalova, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1913.
https://doi.org/10.1182/blood-2018-99-111094
Published: 2018
Journal Articles

Outcome of Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated with or without Rituximab

Heidi Mocikova, MD, PhD, Jozef Michalka, MD, Jan Koren, Pavla Stepankova, Alexander Wild, Ludek Raida, MD, Jana Markova, MD, Zdenek Kral, Marek Trneny, MD, Karel Indrak, MD, Prof., Jiri Mayer, M.D., PhD., Prof., Tomas Kozak, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 4878.
https://doi.org/10.1182/blood.V120.21.4878.4878
Published: 2012
Journal Articles

Dose-Escalation with BEACOPP Escalated Is Superior to ABVD In the Combined-Modality Treatment of Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial

Andreas Engert, MD, Peter Borchmann, MD, Annette Pluetschow, Bastian von Tresckow, Jana Markova, Felicitas Hitz, Zdenek Kral, Richard Greil, MD, Max S Topp, Matthias Villalobos, Josee M. Zijlstra, Martin Soekler, Harald Stein, MD, Hans-Theodor Eich, Rolf-Peter Mueller, Michael Fuchs, Volker Diehl
Journal: Blood
Blood (2010) 116 (21): 765.
https://doi.org/10.1182/blood.V116.21.765.765
Published: 2010
Journal Articles

Management of Relapsed/Refractory Hodgkin Lymphomas After ASCT in Czech Republic.

Heidi Mocikova, Robert Pytlik, MD, Ludek Raida, Pavel Zak, Jana Markova, Zdenek Kral, Katerina Steinerova, Veronika Valkova, Marie Trnkova, Blanka Vackova, David Pohlreich, Edgar Faber, MD, Ass., Prof., Karel Indrak, David Belada, MD, PhD., Tomas Kozak, Jiri Mayer, Antonin Vitek, Vladimir Koza, MD, Marek Trneny
Journal: Blood
Blood (2009) 114 (22): 4357.
https://doi.org/10.1182/blood.V114.22.4357.4357
Published: 2009
Journal Articles

Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and Involved Field Radiotherapy (IF-RT) Is Superior to 4 Cycles of ABVD and IFRT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial

Peter Borchmann, Andreas Engert, Annette Pluetschow, Michael Fuchs, Jana Markova, Andreas Lohri, Zdenek Kral, Richard Greil, Max Topp, Matthias Villalobos, Jose Zijlstra, MD, Martin Soekler, Harald Stein, Hans Theodor Eich, Rolf Peter Mueller, Volker Diehl
Journal: Blood
Blood (2008) 112 (11): 367.
https://doi.org/10.1182/blood.V112.11.367.367
Published: 2008